An arm of the European Medicines Agency (EMA) has recommended expanding the European approval of Johnson & Johnson‘s Tecvayli (teclistamab) to treat adults with…
Myeloma
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Latest news
Discussion
I sit in the waiting room with a half-read magazine on my lap and realize that I haven’t turned a single page. The clock on…
Discussion
I live in Southern California wine country. It’s harvest season here. Workers are plucking grapes from acres of vineyards, sending them off to the crush…
Discussion
The U.S. Food and Drug Administration (FDA) has given GT Biopharma a green light to start a Phase…
Discussion
I sit at the kitchen table late at night with a notebook open in front of me. My mum is asleep in the next room.
Discussion
Artificial intelligence (AI) may help design better CAR T-cell therapies to treat myeloma and other cancers, a study showed. An AI-designed CAR…


